ImmuPharma plc (LON:IMM – Get Free Report) shares fell 11.4% during mid-day trading on Friday . The company traded as low as GBX 2.71 ($0.03) and last traded at GBX 3.10 ($0.04). 30,011,082 shares traded hands during trading, an increase of 48% from the average session volume of 20,325,906 shares. The stock had previously closed at GBX 3.50 ($0.04).
ImmuPharma Trading Up 29.1 %
The business’s fifty day moving average price is GBX 1.40 and its 200 day moving average price is GBX 1.65. The firm has a market capitalization of £18.82 million, a price-to-earnings ratio of -452.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Further Reading
- Five stocks we like better than ImmuPharma
- Why Invest in High-Yield Dividend Stocks?
- Zymeworks in Focus for Insider Activity: Catalysts Ahead
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Kura Sushi Stock Dips Into a Hot Buying Opportunity
- How to Use the MarketBeat Excel Dividend Calculator
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
